Siolta Therapeutics

Leverages deep knowledge of the human microbiome to develop live biotherapeutic products (LBPs) and diagnostics for the prevention and treatment of a wide range of diseases including atopic diseases, women’s health, and rare pediatric indications for which limited or no treatment options exist.